financetom
Business
financetom
/
Business
/
US jury deadlocked in Arm trial against Qualcomm, still deliberating
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US jury deadlocked in Arm trial against Qualcomm, still deliberating
Dec 20, 2024 12:01 PM

(Reuters) -A jury in U.S. federal court in Delaware on Friday said it was deadlocked on one of the questions that it has been asked to resolve in Arm Holdings' lawsuit against Qualcomm ( QCOM ), but is still deliberating the two other questions before it.

Arm's lawsuit against Qualcomm ( QCOM ) asks for the destruction of chip designs it acquired from Nuvia for $1.4 billion in 2021. Nuvia's technology has become the basis of Qualcomm's ( QCOM ) push into the personal computer market.

At stake in the case, in which Arm is suing its biggest customer, is the fate of Qualcomm's ( QCOM ) expansion into new markets using Nuvia's technology and whether Arm can continue to be viewed as a neutral player throughout the chip industry.

Nuvia and Qualcomm ( QCOM ) both had license agreements with Arm, and Qualcomm ( QCOM ) sought to transfer Nuvia's designs to itself after buying the startup company. Arm objected that Nuvia needed its permission to do so and terminated Nuvia's license, ticking off the legal battle.

The case requires a unanimous verdict from the eight-person jury on three questions. The first of those questions was whether Nuvia breached its agreement with Arm, and the jury said Friday it was deadlocked.

The jury said it is still debating the two other questions, which are whether Qualcomm ( QCOM ) breached Nuvia's Arm license agreement and whether Qualcomm's ( QCOM ) central processor designs are properly licensed under its own agreement with Arm.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wescco International Completes $30 Million Acquisition of EntroCIM
Wescco International Completes $30 Million Acquisition of EntroCIM
Jun 5, 2024
08:45 AM EDT, 06/05/2024 (MT Newswires) -- Wesco International ( WCC ) said Wednesday that it has completed its $30 million purchase of entroCIM, a web-based application that provides remote monitoring of commercial facilities. The deal included potential additional payouts based on entroCIM's performance. Price: 179.53, Change: +6.93, Percent Change: +4.02 ...
NBA nears TV deals worth $76 billion, WSJ reports
NBA nears TV deals worth $76 billion, WSJ reports
Jun 5, 2024
June 5 (Reuters) - The National Basketball Association is close to finalizing separate deals with NBC, Disney's ( DIS ) ESPN ( DIS ) and Amazon ( AMZN ) that would bring in about $76 billion in media revenue over 11 years, the Wall Street Journal reported on Wednesday citing people familiar with the matter. ...
Mandalay Resources Intercepts Gold at 2 'Highly Prospective' Targets Near Bjorkdal Mine in Sweden
Mandalay Resources Intercepts Gold at 2 'Highly Prospective' Targets Near Bjorkdal Mine in Sweden
Jun 5, 2024
08:45 AM EDT, 06/05/2024 (MT Newswires) -- Mandalay Resources ( MNDJF ) , which lost 3.5% yesterday, on Wednesday highlighted results from its regional target testing drill campaigns about 6 kilometers to the southwest of the Bjorkdal Mine. The company said it drilled 26 holes and 6,295 meters of diamond drilling to test high-priority regional targets near the mine. The...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
Jun 5, 2024
June 5 (Reuters) - The companies manufacturing COVID-19 vaccines said data from animals studies showed their 2024-25 shots targeting the JN.1 variant that was dominant earlier this year could neutralize newer subvariants such as KP.2 much better than the older shots. Pfizer ( PFE ) and its partner BioNTech will be ready to supply the updated vaccines immediately upon approval,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved